Outcome in refractory depression

Journal of Affective Disorders

Volumn 54, Issue 3, 1999, Pages 287-294

  Shergill, S S ^a   Robertson, M M ^b   Stein, G ^c   Bernadt, M ^c   Katona, C L E ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Farnborough Hospital   (United Kingdom)

Author keywords

Lithium augmentation; Outcome; Resistant depression

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM; LOFEPRAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; TREATMENT OUTCOME;

ADULT; AGED; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 0032800710     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(98)00201-8     Document Type: Article

References (28)

1. Akiskal H.S. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J. Clinical Psychopharmacology. 16(2 (Suppl. 1)):1996;4-14.
2. Austin M.P.V., Souza F.G.M., Goodwin G.M. Lithium augmentation in antidepressant-resistant patients. A quantitative analysis. Brit. J. Psychiatry. 159:1991;510-514.
3. Beck A.T., Ward C.H., Mendelson M.et al. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571.
4. Brugha T.S., Cragg D. The list of threatening experiences: The reliability and validity of a brief life event questionnaire. Acta Psychiatrica Scand. 82:1990;77-81.
5. Carney M.W.P., Roth M., Garside R.F. The diagnosis of depressive syndromes and the prediction of ECT response. Brit. J. Psychiatry. 11:1965;659-674.
6. Causemann B., Muller-Oerlinghausen B. The long-term outcome of depressive illness. Brit. J. Psychiatry. 153:1988;752-757.
7. Endicott J., Spitzer R.L. A diagnostic interview - The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844.
8. Goodwin G.M. Recurrence of mania after lithium withdrawal. Brit. J. Psychiatry. 164:1994;149-152.
9. Hamilton M. Development of a rating scale for primary depressive illness. Brit. J. Social and Clinical Psychology. 6:1967;278-296.
10. Katona, C.L.E., Refractory depression. In: Montgomery, S., Katona, C.L.E., Sensky, T. (Eds.), Psychiatry in Europe: The challenge for the 1990s, Gaskell Press, 1994.
11. Katona C.L.E., Abou-Saleh M.T., Harrison D.A.et al. Placebo controlled trial of lithium augmentation of fluoxetine and lofepramine. Brit. J. Psychiatry. 166:1994;80-87.
12. Keller M.B., Shapiro R.W., Lavori P.W.et al. Relapse in major depressive disorder. Analysis with the life table. Arch. Gen. Psychiatry. 39:1982;911-915.
13. Keller M.B., Lavori P.W., Mueller T.I.et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch. Gen. Psychiatry. 49:1992;809-816.
14. Keller M.B., Klerman G.L., Lavori P.W.et al. Long-term outcome of episodes of major depression. J. Am. Med. Assoc. 252:1984;788-792.
15. Kiloh et al., 1988. Author: Please supply details.
16. Klein, D.F., Davis, J.M., 1969. Diagnosis and Drug Treatment of Psychiatric Disorder, Williams and Wilkins, Baltimore.
17. Lee A.S., Murray R.M. The long-term outcome of Maudsley depressives. Brit. J. Psychiatry. 153:1988;741-751.
18. Mander A.J. Is there a lithium withdrawal syndrome. Brit. J. Psychiatry. 149:1986;498-501.
19. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Brit. J. Psychiatry. 134:1979;382-389.
20. Nierenberg A., Price L.H., Charney D.S., Heninger G.R. After lithium augmentation: A retrospective follow-up of patients with antidepressant-refractory depression. J. Affect. Disorders. 18:1990;167-175.
21. O'Leary D.A., Lee A.S. Seven year prognosis in depression: Mortality and readmission risk in the Nottingham ECT cohort. Brit. J. Psychiatry. 169:1996;423-429.
22. Piccinelli M., Wilkinson G. Outcome of depression in psychiatric settings. Brit. J. Psychiatry. 164:1994;297-304.
23. Schou M., Weeke A. Did manic depressive patients who committed suicide receive prophylactic or continuation treatment at the time? Brit. J. Psychiatry. 153:1988;324-327.
24. Solomon D.A., Kellar M.B., Leon A.C. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch-Gen. Psychiatry. 54(11):1997;1001-1006.
25. Spitzer, R.L., Endicott, J., Robins, E., 1975. Research Diagnostic Criteria (RDC), Biometrics Research, New York State Psychiatric Institute, New York.
26. Stein G., Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Brit. J. Psychiatry. 162:1993;634-640.
27. Thase, M.E., Rush, A.J., 1995. Treatment resistant depression. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 1081-1097.
28. Winokur G., Coryell W., Keller M.et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch. Gen. Psychiatry. 50:1993;457-465.